Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kynurenine Pathway Metabolites as Novel Translational Biological Markers of Irritable Bowel Syndrome: Relationship to Gastrointestinal Function, Cognition and Co-morbid Depression

NCT01304355 is registered in ClinicalTrials.gov with University College Cork as lead sponsor.

NCT NCT01304355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01304355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kynurenine Pathway Metabolites as Novel Translational Biological Markers of Irritable Bowel Syndrome: Relationship to Gastrointestinal Function, Cognition and Co-morbid Depression
Lead sponsor
University College Cork
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
January 31, 2012
Enrollment
85 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome